Track the latest insights on amoxicillin trihydrate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Get real-time access to monthly/quarterly/yearly prices Request Sample
During the second quarter of 2026, the amoxicillin trihydrate prices in the USA reached 23134 USD/MT in June. The price increase was influenced by steady demand from pharmaceutical manufacturers and stable procurement activity from healthcare suppliers. Higher costs for key pharmaceutical intermediates, quality control requirements, and compliance related expenses supported upward price movement. Domestic production and inventory management practices also affected pricing, as buyers maintained supply availability amid consistent antibiotic demand.
During the second quarter of 2026, the amoxicillin trihydrate prices in China reached 22106 USD/MT in June. The price movement was supported by consistent export demand and stable activity from antibiotic manufacturers. Production costs remained influenced by raw material availability, energy expenses, and operational conditions across pharmaceutical production facilities. Competitive supplier activity limited stronger price increases, but manufacturers continued to adjust offers based on production economics and order volumes.
During the second quarter of 2026, the amoxicillin trihydrate prices in Germany reached 23362 USD/MT in June. Prices increased due to higher sourcing costs, strict pharmaceutical quality standards, and continued demand from healthcare and drug manufacturing sectors. European buyers focused on dependable supply channels, which supported stable procurement activity. Compliance requirements related to pharmaceutical production and import controls also influenced overall market costs.
During the second quarter of 2026, the amoxicillin trihydrate prices in India reached 23790 USD/MT in June. The price rise was supported by strong domestic pharmaceutical demand and continued manufacturing activity from antibiotic producers. Raw material availability, production expenses, and export commitments influenced supplier pricing during the quarter. Indian manufacturers adjusted prices based on changing input costs and procurement conditions.
During the second quarter of 2026, the amoxicillin trihydrate prices in Brazil reached 21940 USD/MT in June. The increase in prices was driven by steady pharmaceutical demand and changes in import and distribution costs. Brazil continued to rely on consistent supply availability for antibiotic manufacturing and healthcare applications, supporting market activity. Higher logistics expenses and supplier pricing adjustments influenced the overall cost structure. Pharmaceutical companies maintained procurement activity to ensure availability, which supported stable market conditions.
During the fourth quarter of 2025, the amoxicillin trihydrate prices in the USA reached 22080 USD/MT in December. Prices moved upward due to stronger procurement activity from pharmaceutical formulators and contract manufacturers. Supply discipline among domestic producers limited spot market availability, while compliance related manufacturing costs remained elevated. Import dependency for key intermediates added cost pressure amid extended lead times.
During the fourth quarter of 2025, the amoxicillin trihydrate prices in China reached 20920 USD/MT in December. The market experienced downward pressure driven by ample production output and subdued export demand. Manufacturers operated at healthy utilization rates, leading to comfortable inventory positions. Competitive pricing among domestic suppliers intensified as export orders slowed.
During the fourth quarter of 2025, the amoxicillin trihydrate prices in Germany reached 22141 USD/MT in December. Prices strengthened due to consistent pharmaceutical sector demand and limited regional supply availability. Regulatory compliance expenses and higher operational overheads constrained producer margins, prompting price adjustments. Imports faced logistical inefficiencies, increasing landed costs.
During the fourth quarter of 2025, the amoxicillin trihydrate prices in India reached 22748 USD/MT in December. Prices softened as export demand moderated and domestic supply remained sufficient. Manufacturers benefited from stable raw material sourcing and efficient production cycles. Aggressive competition among exporters led to pricing flexibility in international tenders. Domestic pharmaceutical consumption remained steady but did not offset weaker overseas orders.
During the fourth quarter of 2025, the amoxicillin trihydrate prices in Brazil reached 20475 USD/MT in December. The market trended lower due to reduced import costs and cautious buying by pharmaceutical manufacturers. Adequate stock levels limited urgent procurement. Currency stability supported predictable import pricing, while subdued healthcare spending constrained demand growth. Suppliers offered competitive pricing to maintain market share. Additionally, streamlined distribution networks reduced logistical expenses.
During the third quarter of 2025, the amoxicillin trihydrate prices in the USA reached 21520 USD/MT in September. Pricing in this quarter was influenced by weaker procurement activity from pharmaceutical manufacturers, who adjusted inventories in response to reduced production schedules. Supply conditions also eased as import shipments from Asia moved more smoothly due to improved freight availability and lower shipping premiums.
During the third quarter of 2025, the amoxicillin trihydrate prices in China reached 21370 USD/MT in September. Prices declined due to moderate demand from formulation units, which operated at conservative utilization rates amid subdued export orders. Supply availability increased as several large producers maintained steady output, supported by stable feedstock availability. Export-related logistics benefited from reduced container freight costs throughout the quarter, easing pricing pressure.
During the third quarter of 2025, the amoxicillin trihydrate prices in Germany reached 21475 USD/MT in September. Prices moved downward due to lower procurement volumes from drug formulation companies, which operated under cautious purchasing strategies. Import supply remained sufficient as Asian producers continued to dispatch shipments with shorter lead times, aided by moderated freight surcharges. Domestic manufacturers experienced steady operational conditions, which helped ensure stable market availability.
During the third quarter of 2025, the amoxicillin trihydrate prices in India reached 23500 USD/MT in September. Prices declined due to reduced purchasing momentum from domestic formulation companies, which held adequate inventories from earlier procurement cycles. Supplies from large producers remained stable, supported by the steady availability of key precursors. Import flows benefited from lower freight costs and improved port clearance speeds, reducing overall input costs for manufacturers.
During the third quarter of 2025, the amoxicillin trihydrate prices in Brazil reached 21000 USD/MT in September. Prices weakened as demand from pharmaceutical processors softened, reflecting slower production activity in the finished dosage segment. Supply conditions improved due to timely imports from Asian suppliers and reduced freight charges on long-haul routes. Domestic logistics, including port handling and trucking networks, performed consistently, limiting cost additions.
During the second quarter of 2025, the amoxicillin trihydrate prices in the USA reached 25834 USD/MT in June. Pricing in this quarter was impacted by softening demand from downstream pharmaceutical manufacturers as formulation volumes began moderating. Import supplies were adequate, with improved shipment scheduling from Asian producers. However, certain logistics components, such as warehousing and inland transportation costs, remained elevated.
During the second quarter of 2025, the amoxicillin trihydrate prices in China reached 25260 USD/MT in June. Prices showed downward movement as domestic demand moderated, with formulation companies balancing stocks more conservatively. Production rates among major API manufacturers remained steady, supported by consistent input availability. Export logistics benefited from declining ocean-freight charges and improved port clearance efficiency. Domestic distribution costs were manageable, though some inland transport expenses remained relatively firm.
During the second quarter of 2025, the amoxicillin trihydrate prices in Germany reached 25936 USD/MT in June. Prices declined due to moderated procurement activities from drug formulators, who faced lower production requirements. Import availability from Asia improved as freight conditions eased. Domestic manufacturing operations remained stable, ensuring a consistent supply in the local market. Distribution costs were relatively steady, although some regional trucking charges remained elevated.
During the second quarter of 2025, the amoxicillin trihydrate prices in India reached 27105 USD/MT in June. Prices softened as demand from pharmaceutical manufacturers moderated following earlier stockpiling. Supply availability improved with consistent output from domestic API producers. Import-dependent manufacturers benefited from reduced freight and handling charges. Domestic logistics operated steadily, though certain regions experienced isolated cost increases linked to transportation constraints.
During the second quarter of 2025, the amoxicillin trihydrate prices in Brazil reached 25990 USD/MT in June. Prices decreased as market demand from formulators remained moderate. Supplies through imports showed improvement, aided by reduced container freight costs and predictable shipment schedules. Domestic transportation networks functioned steadily, keeping logistics costs stable. Exchange rate conditions did not create major volatility in imported input prices.
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing amoxicillin trihydrate prices.
Q2 2026:
The amoxicillin trihydrate price index in Europe showed an upward movement due to firm pharmaceutical demand and increasing production related expenses. Germany recorded higher prices as manufacturers and buyers focused on quality controlled supply channels. The European market was influenced by strict regulatory standards, manufacturing compliance requirements, and dependable sourcing needs. Pharmaceutical companies continued procurement activity to maintain antibiotic production levels, supporting price stability. Higher operational expenses across production and distribution networks also contributed to increased market costs. Supplier negotiations remained focused on reliability and quality assurance, shaping pricing conditions across European markets during the quarter.
Q4 2025:
Amoxicillin trihydrate price index in Europe reflected a bullish trend. Prices were supported by consistent pharmaceutical demand and tight regional supply. Regulatory compliance costs and higher production overheads constrained output flexibility. Import logistics faced inefficiencies, elevating landed costs. Buyers prioritized supply security, sustaining steady procurement activity. Overall, the regional market maintained upward momentum.
Q3 2025:
During the third quarter of 2025, the amoxicillin trihydrate price index in Europe reflected a downward movement driven by subdued procurement from pharmaceutical formulation companies and consistent API availability. Import flows from Asian producers improved due to lower freight rates and shorter transit times, which softened cost pressures. Domestic logistics performed smoothly, with trucking and warehousing costs stabilizing across major European hubs. Regulatory compliance expenses remained constant, enabling predictable operational budgeting for manufacturers.
Q2 2025:
During the second quarter of 2025, the amoxicillin trihydrate price index in Europe declined due to moderated demand from formulation units and improved API availability. Import logistics saw gradual improvements as freight costs began easing from earlier highs. Domestic transportation remained functional, though certain regions experienced minor distribution cost pressures. Production within Europe continued steadily with stable raw material access. Regulatory conditions did not introduce new overhead burdens. These combined factors contributed to softer pricing across the region.
This analysis can be extended to include detailed amoxicillin trihydrate price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
Q2 2026:
The amoxicillin trihydrate price index in North America increased due to stable healthcare demand and firm pharmaceutical manufacturing activity. The USA market experienced higher pricing as suppliers managed production costs, quality requirements, and inventory planning. Manufacturers continued to prioritize consistent supply availability for pharmaceutical applications, supporting stronger pricing conditions. Raw material expenses, compliance requirements, and supply chain management influenced market movements. Buyers maintained procurement activity to avoid supply disruptions, which supported steady demand. The regional market remained balanced, with pricing shaped by production economics and pharmaceutical sector requirements.
Q4 2025:
Amoxicillin trihydrate price index in North America showed strengthening as market fundamentals remained supportive. Controlled production rates limited excess supply, ensuring a balanced availability across the region. Stable healthcare demand, driven by consistent prescription volumes and hospital procurement, provided a reliable consumption base. Supply chain challenges, including longer lead times for raw materials and packaging components, increased cost pressures for manufacturers and distributors.
Q3 2025:
During the third quarter of 2025, the amoxicillin trihydrate price index in North America declined due to easing demand from drug formulators and improved API availability in the market. Import supplies benefited from reduced shipping costs and more predictable freight scheduling. Domestic logistics, including trucking networks, showed improved performance, lowering overall transportation expenses. Raw material markets maintained stability, allowing domestic API processors to operate with consistent input costs.
Q2 2025:
During the second quarter of 2025, the amoxicillin trihydrate price index in North America weakened as demand from pharmaceutical processors moderated. Import supplies improved due to stabilizing freight costs and better shipping reliability. Domestic logistics infrastructure performed adequately, though some trucking delays added mild cost pressures. Upstream material markets showed stability, supporting consistent production activity. Regulatory compliance requirements remained unchanged. These combined trends contributed to overall lower market prices.
Specific amoxicillin trihydrate historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Q2 2026:
The study looks at amoxicillin trihydrate pricing patterns and price charts in the Middle East and Africa, taking into consideration elements that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical concerns.
Q4 2025:
The report explores the amoxicillin trihydrate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q3 2025:
As per the amoxicillin trihydrate price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
In addition to region-wise data, information on amoxicillin trihydrate prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Q2 2026:
The Asia Pacific amoxicillin trihydrate market showed upward price movement supported by strong pharmaceutical manufacturing activity and export demand. China and India remained key production centers, with pricing influenced by raw material costs, production efficiency, and supplier competition. Growing antibiotic consumption and continued pharmaceutical sector activity supported demand conditions. Manufacturers adjusted prices according to operational expenses and order requirements. Regional supply remained available, but quality standards and production compliance affected pricing decisions. The market reflected a balance between competitive supplier activity and rising manufacturing costs across major producing countries.
Q4 2025:
Asia Pacific amoxicillin trihydrate prices softened as production capacity across key manufacturing hubs remained sufficient. Manufacturers operated with comfortable inventory levels, reducing urgency for aggressive pricing strategies. Export demand moderated as international buyers adjusted procurement volumes, adding further pressure on regional suppliers. Intense competition among producers led to flexible pricing to retain market share. At the same time, efficient logistics networks and stable raw material sourcing helped contain operational costs.
Q3 2025:
In the third quarter of 2025, amoxicillin trihydrate prices in the Asia Pacific region weakened due to cautious buying among formulation companies and stable API output levels. Key producing markets maintained consistent production supported by steady access to intermediates. Export-linked logistics improved as freight costs declined, reducing cost burdens for API shipments. Regional distribution costs also moderated with improved road and port efficiencies. Price competition among suppliers further influenced downward adjustments.
Q2 2025:
In the second quarter of 2025, amoxicillin trihydrate prices in the Asia Pacific decreased due to cautious purchasing by formulation companies and steady API production. Export logistics began improving, supported by softening freight rates. Regional transportation networks remained functional, though certain markets saw moderate logistics costs. Competitive pricing among regional suppliers added downward pressure. Stable upstream inputs ensured continuous production levels, contributing to softer pricing.
This amoxicillin trihydrate price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Q2 2026:
The Latin America amoxicillin trihydrate market recorded higher prices due to supply chain expenses and continued demand from healthcare applications. Brazil remained an important market where pricing was influenced by import dependence, distribution costs, and supplier availability. Pharmaceutical companies focused on securing stable supplies, supporting procurement activity during the quarter. International sourcing conditions and logistics expenses affected overall market pricing. Regional buyers continued to prioritize reliable pharmaceutical grade material, which supported steady demand. The market remained influenced by external supply factors and healthcare sector requirements across Latin American countries.
Q4 2025:
Latin American markets witnessed mild price easing as supply conditions remained favorable. Adequate inventories across distribution channels reduced the need for urgent replenishment, encouraging cautious procurement behavior. Pharmaceutical manufacturers and distributors adopted conservative purchasing strategies amid stable downstream demand. Currency stability across key importing countries supported predictable import costs, limiting sudden pricing adjustments.
Q3 2025:
In the third quarter of 2025, amoxicillin trihydrate prices in Latin America decreased due to moderated pharmaceutical manufacturing activity and improved import arrivals. Freight rates for long-distance shipments from Asia declined, easing input cost pressures. Domestic logistics networks performed steadily across regional markets, preventing additional inflationary pressure. Currency conditions remained relatively stable, limiting cost volatility for imported materials.
Q2 2025:
In the second quarter of 2025, amoxicillin trihydrate prices in Latin America declined as pharmaceutical manufacturing activity remained moderate. Import supplies improved due to gradual reductions in container freight charges. Domestic logistics maintained stable performance, preventing major cost increases. Currency fluctuations remained manageable and did not create significant price volatility. Supplier competition further encouraged price reductions. These combined factors contributed to weakened market pricing.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
IMARC's latest publication, “Amoxicillin Trihydrate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the amoxicillin trihydrate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of amoxicillin trihydrate at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed amoxicillin trihydrate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting amoxicillin trihydrate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

The global amoxicillin trihydrate market size reached 85.98 Thousand Tons in 2025. By 2034, IMARC Group expects the market to reach 117.39 Thousand Tons, at a projected CAGR of 3.52% during 2026-2034. The market is primarily driven by the consistent utilization in pharmaceutical manufacturing, driven by expanding antibiotic consumption, strong demand for generic formulations, ongoing capacity expansion in major producing countries, and stable access to key intermediates supporting continuous API production.
Amoxicillin trihydrate is a semi synthetic penicillin antibiotic used for treating bacterial infections. It is the trihydrate form of amoxicillin, with the molecular formula C16H19N3O5S·3H2O. The product is generally available as a white or almost white crystalline powder and has limited solubility in water. It works by blocking bacterial cell wall formation, which helps stop bacterial growth. Amoxicillin trihydrate is mainly used in pharmaceutical formulations such as capsules, tablets, and oral suspensions. It is widely applied in the treatment of respiratory infections, urinary tract infections, skin infections, and other bacterial diseases. Pharmaceutical manufacturers require high purity material with consistent quality to ensure safe and effective medicine production.
| Key Attributes | Details |
|---|---|
| Product Name | Amoxicillin Trihydrate |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Amoxicillin Trihydrate Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.